P. L. Haslam (London, United Kingdom), T. Nukiwa (Sendai, Japan)
Comparison of fibroblastic foci scoring systems in usual interstitial pneumonia (UIP)
K. R. Flaherty, T. V. Colby, W. D. Travis, G. B. Toews, F. J. Martinez (Ann Arbor, Scottsdale, Washington, United States Of America)
|  |
Expression of apoptotic markers in patients with idiopathic pulmonary fibrosis
M. Plataki, A. Koutsopoulos, K. Darivianaki, G. Delides, N. M. Siafakas, D. Bouros (Heraklion, Alexandroupolis, Greece)
| |
Inverse correlation of TLC and MMP-8/ -9 in BALF of UIP patients
M. Kolb, J. Kirschner, K. Meyer, J. Blechschmidt, M. Schmidt (Wuerzburg, Germany; Hamilton, Canada)
|  |
Studies on bronchoalveolar lavage lymphocytes (L-BAL) apoptosis in pulmonary sarcoidosis (PS) and silicosis
P. Kopinski, J. Soja, A. Szlubowski, U. Jedynak, J. Trojan, K. Sladek, J. Szczeklik (Bydgoszcz, Krakow, Poland)
| |
IFN-γ and IL4 levels in bronchoalveolar lavage of patients affected by different stages of sarcoidosis
A. Capelli, A. Di Stefano, I. Gnemmi, C. Vecchio, C. F. Donner (Veruno, Italy)
| |
Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis
N. Nikiforakis, A. Fossi, A. Leonini, M. G. Perari, C. Vaggeggini, A. Collodoro, P. Rottoli (Siena, Italy)
| |
The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis
B. M. Chen, Z. H. Tong, U. Costabel, J. Guzman (Essen, Bochum, Germany)
| |
Granulocyte-macrophage colony stimulating factor inhalation therapy as a treatment for pulmonary alveolar proteinosis
R. Tazawa, O. Ishimoto, H. Ohta, T. Suzuki, M. Maemondo, M. Ebina, K. Hagiwara, K. Nakata, T. Nukiwa (Sendai, Tokyo, Japan)
| |